These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6205565)

  • 1. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 2. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study.
    Oxenstierna G; Edman G; Iselius L; Oreland L; Ross SB; Sedvall G
    J Psychiatr Res; 1986; 20(1):19-29. PubMed ID: 2423688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 5. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of the three major monoamine metabolites in CSF by HPLC with electrochemical detection.
    Van Bockstaele M; Dillen L; Claeys M; De Potter WP
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):304-5. PubMed ID: 6187306
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women.
    Wode-Helgodt B; Sedvall G
    Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302
    [No Abstract]   [Full Text] [Related]  

  • 9. Biogenic amines and affective disorders.
    Schildkraut JJ
    Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemistry of the augmenting-reducing response in visual evoked potentials.
    von Knorring L; Perris C
    Neuropsychobiology; 1981; 7(1):1-8. PubMed ID: 6162127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are monoamine metabolites in cerebrospinal fluid worth measuring?
    Potter WZ; Manji HK
    Arch Gen Psychiatry; 1993 Aug; 50(8):653-6. PubMed ID: 7688211
    [No Abstract]   [Full Text] [Related]  

  • 12. Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source?
    Csernansky JG; Faull KF; Pfefferbaum A
    Psychiatry Res; 1988 Sep; 25(3):361-3. PubMed ID: 2460883
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in the metabolism of biogenic amines in alcoholism--especially regarding CSF monoamine metabolites and serum DBH activity.
    Kato N; Takahashi S; Tani N; Iwase N; Odani K
    Alcohol Clin Exp Res; 1979 Jan; 3(1):24-7. PubMed ID: 371446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
    Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
    Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The probenecid test and its application to research in schizophrenia].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):252-5. PubMed ID: 6085620
    [No Abstract]   [Full Text] [Related]  

  • 16. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
    Bowers MB; Heninger GR
    Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.
    Bowers MB; Study RE
    Psychopharmacology (Berl); 1979 Mar; 62(1):17-22. PubMed ID: 220657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modifications of cerebral amine metabolism in psychiatric illness].
    Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment.
    Härnryd C; Bjerkenstedt L; Grimm VE; Sedvall G
    Psychopharmacology (Berl); 1979 Aug; 64(2):131-4. PubMed ID: 115032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.